In a closely watched appeal before the U.S. Court of Appeals for the Federal Circuit, Altria Client Services LLC, Philip Morris Products S.A., and Philip Morris USA, Inc. brought an infringement action against RAI Strategic Holdings, Inc. and R.J. Reynolds Vapor Company involving seven U.S. patents covering electronic smoking article technology. Filed on May 23, 2023, and closed just 258 days later on February 5, 2024, the appeal was resolved through voluntary dismissal under Fed. R. App. P. 42(b), with each side bearing its own costs — a resolution suggesting a negotiated resolution or commercial settlement between two of the largest players in the tobacco and vaping industry.

This case carries significant strategic weight for IP professionals and R&D teams operating in the electronic nicotine delivery systems (ENDS) space. With seven patents at stake — covering charging cases for personal vaporizers, control bodies for electronic smoking articles, and tobacco-containing smoking articles — the underlying portfolio represents a core battleground in the ongoing patent wars between legacy tobacco giants seeking to dominate the next generation of nicotine delivery products. The voluntary dismissal at the appellate level, rather than a merits-based ruling, leaves the enforceability and claim scope of these patents unresolved in the public record, creating both risk and opportunity for competitors and innovators in the sector.

Case Overview

The Parties

The Patents at Issue

The seven patents at issue cover foundational technologies in electronic smoking articles and personal vaporizing devices. US9901123B2 and US9839238B2 relate to control bodies and operational mechanisms for electronic cigarettes — the core hardware that governs heating, power delivery, and user experience. US8314591B2 covers electrical systems relevant to tobacco-containing smoking articles, while US9814268B2 and US9930915B2 address structural and functional design elements of e-cigarette components. US10432542B2 and US10492542B1 extend protection to charging cases for personal vaporizing inhalers, a growing product category as rechargeable pod-based systems have come to dominate the consumer vaping market.

• • US9901123B2
• • US9839238B2
• • US8314591B2
• • US9814268B2
• • US10432542B2
• • US10492542B1
• • US9930915B2

Legal Representation

Defendant Counsel: Law Offices of Charles B. Molster, III PLLC (lead: Charles Molster III)

Litigation Timeline & Procedural History

This case originated as an appeal to the United States Court of Appeals for the Federal Circuit — the exclusive appellate court for U.S. patent matters — meaning a district court or administrative tribunal had already rendered a decision on some or all issues before the parties escalated to this venue. The Federal Circuit’s specialized jurisdiction in patent law makes its rulings on infringement, validity, and claim construction highly authoritative and often precedent-setting for the entire patent litigation ecosystem. The District of Columbia regional designation reflects the administrative context or the parties’ procedural filing choices at the appellate level.

At 258 days from filing to closure, this appeal ran a relatively compressed course for Federal Circuit proceedings, which frequently extend well beyond a year. The case was terminated through voluntary dismissal under Federal Rule of Appellate Procedure 42(b), a mechanism that requires agreement of all parties or a court order. The mutual cost-bearing arrangement — rather than one party absorbing the other’s legal fees — is a classic signature of a negotiated commercial resolution, strongly suggesting a settlement, licensing arrangement, or business agreement was reached between Altria/Philip Morris and RAI/R.J. Reynolds outside of court. No merits ruling, claim construction decision, or validity determination was issued at the appellate level.

The Verdict & Legal Analysis

Outcome

The Federal Circuit dismissed the appeal by mutual agreement of the parties pursuant to Fed. R. App. P. 42(b), with each side ordered to bear its own costs. No damages award, injunctive relief, or royalty determination was issued by the court. Because the termination was voluntary and stipulated, no findings on infringement, patent validity, or claim construction were made in this proceeding — leaving the substantive legal questions surrounding all seven asserted patents unresolved on the public record.

Verdict Cause Analysis

The infringement action and its appellate posture implicate several key legal and strategic considerations common to high-stakes ENDS patent disputes:

• The voluntary dismissal under Fed. R. App. P. 42(b) is a bilateral procedural mechanism that requires mutual consent, distinguishing it from a unilateral withdrawal and strongly implying a negotiated resolution between the parties.
• Each side bearing its own costs — rather than the standard American rule or a fee-shifting order — signals that neither party gained sufficient leverage at the appellate level to extract cost concessions, consistent with a symmetric bargaining position at settlement.
• With seven patents covering overlapping product categories (control bodies, charging cases, tobacco-containing articles), the breadth of the asserted portfolio suggests this dispute was as much about competitive market positioning and cross-licensing as it was about discrete infringement claims.
• Because no Federal Circuit ruling on the merits was issued, the claim scope and validity of all seven patents remain subject to future challenge in subsequent litigation or inter partes review proceedings, preserving enforcement optionality for Altria/Philip Morris.

Legal Significance

1. 1. The absence of a merits ruling means this case creates no binding Federal Circuit precedent on claim construction or infringement standards for electronic smoking article patents, leaving the legal landscape unsettled for third-party competitors in the ENDS market.
2. 2. The survival of all seven patents without a validity determination means RAI and R.J. Reynolds Vapor — and any other party in the vaping space — remain exposed to future assertion of these same patents in new proceedings unless a license or covenant not to sue was part of any underlying settlement.
3. 3. The pattern of appellate-level voluntary dismissal in tobacco/vaping patent disputes reflects a broader industry trend toward commercially negotiated resolutions rather than definitive judicial outcomes, making private licensing intelligence — not just court records — essential for competitive IP strategy in this sector.

Strategic Takeaways

For Patent Attorneys:

• When representing clients in Federal Circuit appeals involving multi-patent portfolios, monitor the cost-allocation structure of any voluntary dismissal order — mutual cost-bearing is a reliable indicator of settlement and may trigger disclosure obligations or affect ongoing parallel proceedings.
• The breadth of the seven-patent portfolio asserted here illustrates the plaintiff’s strategy of claim-stacking across product subsystems; counsel defending ENDS companies should proactively audit exposure across charging, control, and consumable patent families rather than addressing claims in isolation.
• Because no appellate ruling on validity or infringement was issued, these patents retain their presumption of validity under 35 U.S.C. § 282; attorneys advising competitors should consider filing inter partes review petitions at the USPTO to affirmatively challenge claim scope before the next enforcement cycle.
• The use of Fed. R. App. P. 42(b) for dismissal requires attention to whether any district court judgment below was vacated or left intact — parties and counsel should confirm the preclusive effect of any underlying rulings when advising on future litigation exposure.

For IP Professionals:

• In-house IP teams at ENDS companies should treat this voluntary dismissal as a signal that the Altria/Philip Morris portfolio remains active and potentially re-assertable; map your product lines against all seven patent numbers and assess design-around feasibility before the next product cycle.
• Monitor USPTO assignment records and any continuation or continuation-in-part applications stemming from the seven asserted patents — a commercial settlement often precedes a new wave of prosecution activity as the winning licensor reinvests in portfolio expansion.

For R&D Teams:

• Engineering teams developing vaporizer charging cases or e-cigarette control bodies should conduct a targeted FTO review against US10432542B2, US10492542B1, US9901123B2, and US9839238B2 before finalizing hardware architecture, as these patents cover foundational design and operational elements that are difficult to design around late in development.
• The fact that this dispute involved tobacco-containing smoking articles alongside purely electronic devices signals that convergent product designs — hybrid heated tobacco and e-cigarette platforms — carry elevated patent risk and should be reviewed against both traditional tobacco and ENDS patent families.